News
HIV pharma leaders are at Kigali, Rwanda for IAS 2025, touting their latest advancements in HIV and PrEP development on the ...
Asianet Newsable on MSN22m
Adagene Receives FDA Guidance On Future Clinical Development Of Experimental Cancer Drug: Retail Turns OptimisticNeither the mid-stage nor the late-stage trial of Adagene’s drug needs an arm studying the drug as a monotherapy without Merck’s Keytruda, the company said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback